ASX:FTC FinTech Chain (FTC) Stock Price, News & Analysis → Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad) Free FTC Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get FinTech Chain alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About FinTech ChainFinTech Chain Limited, an investment holding company, engages in the provision of system development and information technology services in the People's Republic of China. It also provides point-of-sale machines. The company's products comprise of Payment T+ that includes prepaid card, integrated payment system, and commission assignment system, as well as POS P acquiring system; clearing F.E.A, such as bank identification number based promotion tool system, transaction E- authentication, horizontal clearing and universal points platforms. In addition, It offers cloud-based products, including digital community, T-Linx cloud, community O2O, and E-commerce supply chain services, as well as provides hardware products comprising of T-PAD, T-BOX, TL-007, TL 008/009, and TL Mini. Further, it offers investment management and consultancy services. The company provides its solutions for banking, catering, department store, tourism, and retail industries, as well as for community management. FinTech Chain Limited was incorporated in 2010 and is based in Shenzhen, the People's Republic of China.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> FTC Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive FTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FinTech Chain and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorComputer and Technology Industry Software - Infrastructure Sub-IndustryN/A Current SymbolASX:FTC CUSIPN/A CIKN/A Webwww.ttg.hk Phone86 75 5255 46800FaxN/AEmployees115Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.05 million Net Margins2.11% Pretax MarginN/A Return on EquityN/A Return on Assets3.06% Debt Debt-to-Equity Ratio1,747.53 Current Ratio1.10 Quick Ratio0.71 Sales & Book Value Annual Sales$49.87 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA($0.01) per share Price / BookN/AMiscellaneous Outstanding Shares650,770,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.01 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Qiang Xiong (Age 49)President, CEO & Executive Director Comp: $157.28kMs. Qiuju Gao (Age 41)VP, Deputy CEO, Company Secretary & Executive Director Comp: $899Ms. Man Yi Ho (Age 33)Chief Financial Officer Mr. Carter TsengChief ScientistMs. Daisy GaoMarketing DirectorMr. Kevin XuHuman Resources DirectorMore ExecutivesKey CompetitorsA2B AustraliaASX:A2BAdslotASX:ADSAdveritasASX:AV1AdyenOTCMKTS:ADYYFAEyeNASDAQ:LIDRWView All CompetitorsInsidersChristopher RyanBought 1,500,000 shares on 11/1/2023Total: $16,500.00 ($0.01/share) This page (ASX:FTC) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FinTech Chain Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.